GABARAPL1 and neoplasm: It has also been shown that GABARAPL1 overexpression inhibits tumor growth in vivo and mediate the degradation of DVL2 (Dishevelled 2) through selective autophagy leading to the inhibition of the Wnt pathway whose deregulation has been described to be involved in various diseases such as cancer [50].